Author:
Coates Amanda,Reilly Rachel
Publisher
Springer International Publishing
Reference9 articles.
1. England PH. Quality assurance guidelines for breast pathology services, vol 2. Available from: https://www.gov.uk/government/publications/breast-screening-quality-assurance-guidelines-for-breast-pathology-services/breast-screening-quality-assurance-guidelines-for-screening-pathology-services. Accessed 4 Dec 2021.
2. Morrow M, Strom EA, Bassett LW, Dershaw DD, Fowble B, Harris JR, O’Malley F, Schnitt SJ, Singletary SE, Winchester DP. Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin. 2002;52(5):256–76.
3. Bagnall M, Evans A, Wilson A, Burrell H, Pinder S, Ellis I. When have mammographic calcifications been adequately sampled at needle core biopsy? Clin Radiol. 2000;55(7):548–53.
4. Margolin FR, Kaufman L, Jacobs RP, Denny SR, Schrumpf JD. Stereotactic core breast biopsy of malignant calcifications: diagnostic yield of cores with and cores without calcifications on specimen radiographs. Radiology. 2004;233(1):251–4.
5. Volleamere AJ, Kirwan CC. National survey of breast cancer specimen orientation marking systems. Eur J Surg Oncol. 2013;39(3):255–9.